An interview with Andwele Mwansasu, MD, SIAPS Senior Technical Advisor What innovations in fighting malaria over the past five years have particular promise? Has there been a watershed moment? With decreasing malaria burden all over the world, a lot has been happening in the malaria world to sustain these gains. Countries are able to detect […]
Archive | FeaturedRSS feed for this section
Institutionalizing Robust Quantification Processes and Tools within Guinea’s National Malaria Control Program
By Claude Bahati, Deputy Country Project Director, SIAPS, Guinea Accurate quantification for malaria programs, which involves forecasting the quantities needed and planning for the procurement of appropriate pharmaceuticals and supplies, is essential to ensuring that patients receive a continuous supply of commodities. The US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals […]
TB patients on second-line treatment experience a significant number of adverse effects. Some TB medicines result in adverse effects that, if not continuously monitored, can become serious and/or permanent and may hinder patient adherence to treatment. A number of other risk factors can also impact the safety of patients taking TB medicines, including drug interactions […]
Click on graphic to open larger version.
Bedaqualine (BDQ) is the first new class of antibiotic to come along in decades. Here’s how it’s being introduced to treat drug-resistant TB in many low- and middle-income countries. Scroll over the photos and click for more information.
An online system for monitoring and reporting cases of adverse drug reactions and lack of efficacy of medicines comprehensively addresses the need for improved access to quality, safe, and effective medicines. “The evaluation and analysis of PAIS system in Ukraine has brought out gaps and identified recommendations on operational PAIS system optimization and enhancing its […]
A Q&A with Alan George, SIAPS technical advisor for supply chain management How does strengthening pharmaceutical systems make for stronger supply chains? And how does that translate into access to medicines? Having strong pharmaceutical systems is essential to having an efficient supply chain in the same way that having an efficient supply chain is essential […]
Compiled by Wezi Tjaronda (SIAPS), Samson Mwinga (SIAPS), Harriet Kagoya (SIAPS), and Greatjoy Mazibuko (SIAPS) At the Kaisosi settlement in Rundu, Namibia, antiretroviral therapy (ART) patients who were once lost to follow up (LTFU) are returning for care. One of these patients, Domingos Christophine*, a 39-year-old single mother, began ART at the Kuisebmund clinic in […]
An interview with Sheena Patel, technical advisor for maternal, newborn and child health activities at SIAPS The health of women and children is critical to the overall health and prosperity of a country—and the world. Can you talk a bit about why? The most obvious reason is that when women and children are healthy, they […]
Key to the success of any health systems strengthening project is whether it effects broad, sustainable, institutional change. Sound strategic planning can grow a successful hospital pilot program into a nationwide health intervention that improves lives. The examples below show the SIAPS program’s work in bringing pharmaceutical systems strengthening interventions to scale. Technical Publication: Transforming Pharmaceutical […]